AGAP2 and hepatocellular carcinoma: Furthermore, AGAP2-AS1 promotes cell proliferation, migration, invasion, and EMT progression in hepatocellular carcinoma via AGAP2-AS1/miR-16-5p/ANXA11/AKT axis as ceRNA [16].